Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects.

antipsychotic management oral dyskinesia pseudo-tardive second-generation antipsychotics withdrawal dyskinesia withdrawal-emergent dyskinesia

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Apr 2023
Historique:
accepted: 29 04 2023
medline: 31 5 2023
pubmed: 31 5 2023
entrez: 31 5 2023
Statut: epublish

Résumé

Withdrawal-emergent dyskinesia is a movement disorder that emerges following sudden discontinuation or rapid taper of antipsychotic medication. It is infrequently identified and typically resolves within a few weeks from symptom onset. This case report describes a unique case of reversible oral dyskinesia in a 13-year-old male in the context of concurrent neuroleptic withdrawal and stimulant titration. The extant literature describing tardive dyskinesia is well-established; however, few studies have thoroughly examined withdrawal-emergent dyskinesia and other tardive syndromes. This report highlights the importance of clinician awareness as far as the potential for extrapyramidal symptoms and withdrawal-emergent adverse effects in concomitant management of antipsychotics and stimulants in the child and adolescent populations and may help inform future treatment and management of disorders that would indicate the concurrent use of these psychotropics.

Identifiants

pubmed: 37255893
doi: 10.7759/cureus.38294
pmc: PMC10226429
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e38294

Informations de copyright

Copyright © 2023, Haji Rahman et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Pediatr Health Care. 2012 Mar;26(2):139-45
pubmed: 22360933
Can J Psychiatry. 2019 Jun;64(6):388-399
pubmed: 30791698
Cochrane Database Syst Rev. 2017 Oct 02;10:CD009504
pubmed: 28965364
Noro Psikiyatr Ars. 2016 Jun;53(2):178-180
pubmed: 28360793
EXCLI J. 2014 Oct 13;13:1163-91
pubmed: 26417330
Can J Psychiatry. 2005 Aug;50(9):541-7
pubmed: 16262110
Turk Psikiyatri Derg. 2021;32(4):283-285
pubmed: 34964103
Neurosci Biobehav Rev. 2018 Apr;87:255-270
pubmed: 29428394

Auteurs

Rangin Haji Rahman (R)

Medicine, Saint James School of Medicine, Park Ridge, USA.

Sanjaya Dharmapuri (S)

Psychiatry and Behavioral Sciences, Garfield Park Behavioral Hospital, Chicago, USA.

Classifications MeSH